Jonathan Casto, PA
Medical · South Charleston, WVNPI 1952738577
Payments from drug & device makers
Across 75 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$306
- Novo Nordisk$268
- AstraZeneca$117
- Lilly USA, LLC$107
- Exact Sciences$103
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
- plus $340 from 15 others
What the payments were for
- Food & beverage$1,300100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $306 |
| Novo Nordisk | 19 | $268 |
| AstraZeneca | 7 | $117 |
| Lilly USA, LLC | 5 | $107 |
| Exact Sciences | 5 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Bayer | 2 | $40 |
| GSK | 2 | $33 |
| Medtronic | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Merck | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Novartis | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,300 in reported general payments places this provider in the 60th percentile of 233 medical providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $57,026 |
| OzempicSemaglutide | 27 | $32,736 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $24,774 |
| EliquisApixaban | 18 | $21,802 |
| MounjaroTirzepatide | 17 | $16,354 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $5,984 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $3,965 |
| Duloxetine Hcl | 23 | $3,534 |
| Gabapentin | 73 | $2,748 |
| Aripiprazole | 13 | $2,196 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 82 | $2,066 |
| Atorvastatin Calcium | 205 | $1,934 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $1,726 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,378 |
| Pregabalin | 18 | $1,342 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $268 | $32,73627 claims |
| GSKTrelegy Ellipta | $33 | $24,77435 claims |
| Lilly USA, LLCMounjaro, Olanzapine | $107 | $16,71934 claims |
| Boehringer IngelheimCombivent Respimat | $14 | $5,98413 claims |
| AstraZenecaSymbicort | $117 | $3,96519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 233 medical providers in West Virginia.
Other medical in South Charleston
- Katherine BoggsSouth Charleston$46K
- Katie CarpenterSouth Charleston$26K
- Kellie HanselSouth Charleston$12K
- Holli CaragSouth Charleston$7K
- Lauren ShafferSouth Charleston$6K
- Timothy DouglasSouth Charleston$6K
- Jacqueline McCartySouth Charleston$5K
- Anthony KnellSouth Charleston$4K
- Kelsey MathisSouth Charleston$3K
- Shelley GaumSouth Charleston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.